Stephens & Co. Maintains Overweight on Vericel, Raises Price Target to $58
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst George Sellers maintains an Overweight rating on Vericel (NASDAQ:VCEL) and raises the price target from $56 to $58.
August 02, 2024 | 6:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. analyst George Sellers maintains an Overweight rating on Vericel and raises the price target from $56 to $58.
The Overweight rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100